Personal omics profiling reveals dynamic molecular and medical phenotypes.

Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Cell (Impact Factor: 33.12). 03/2012; 148(6):1293-307. DOI: 10.1016/j.cell.2012.02.009
Source: PubMed

ABSTRACT Personalized medicine is expected to benefit from combining genomic information with regular monitoring of physiological states by multiple high-throughput methods. Here, we present an integrative personal omics profile (iPOP), an analysis that combines genomic, transcriptomic, proteomic, metabolomic, and autoantibody profiles from a single individual over a 14 month period. Our iPOP analysis revealed various medical risks, including type 2 diabetes. It also uncovered extensive, dynamic changes in diverse molecular components and biological pathways across healthy and diseased conditions. Extremely high-coverage genomic and transcriptomic data, which provide the basis of our iPOP, revealed extensive heteroallelic changes during healthy and diseased states and an unexpected RNA editing mechanism. This study demonstrates that longitudinal iPOP can be used to interpret healthy and diseased states by connecting genomic information with additional dynamic omics activity.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Metabolomics comprises the methods and techniques that are used to measure the small molecule composition of biofluids and tissues, and is actually one of the most rapidly evolving research fields. The determination of the metabolomic profile - the metabolome - has multiple applications in many biological sciences, including the developing of new diagnostic tools in medicine. Recent technological advances in nuclear magnetic resonance and mass spectrometry are significantly improving our capacity to obtain more data from each biological sample. Consequently, there is a need for fast and accurate statistical and bioinformatic tools that can deal with the complexity and volume of the data generated in metabolomic studies. In this review, we provide an update of the most commonly used analytical methods in metabolomics, starting from raw data processing and ending with pathway analysis and biomarker identification. Finally, the integration of metabolomic profiles with molecular data from other high-throughput biotechnologies is also reviewed.
    Frontiers in Bioengineering and Biotechnology 01/2015; 3:23. DOI:10.3389/fbioe.2015.00023
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The complex interaction of molecules within a biological system constitutes a functional module. These modules are then acted upon by both internal and external factors, such as genetic and environmental stresses, which under certain conditions can manifest as complex disease phenotypes. Recent advances in high-throughput biological analyses, in combination with improved computational methods for data enrichment, functional annotation, and network visualization, have enabled a much deeper understanding of the mechanisms underlying important biological processes by identifying functional modules that are temporally and spatially perturbed in the context of disease development. Systems biology approaches such as these have produced compelling observations that would be impossible to replicate using classical methodologies, with greater insights expected as both the technology and methods improve in the coming years. Here, we examine the use of systems biology and network analysis in the study of a wide range of rheumatic diseases to better understand the underlying molecular and clinical features.
    The Korean Journal of Internal Medicine 03/2015; 30(2):148-160. DOI:10.3904/kjim.2015.30.2.148
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objectives of this report are to: ƒ analyse and map out the future development of BMI towards ultimate clinical utility such that it fulfils stakeholder needs (researchers, clinicians, health system providers, patients, industry and regulatory authorities), while paying attention to the ethical and security considerations, ƒ present BMI approaches that can help the ‘translation’ of biomedical research results into clinical practice, ƒ present methods of integration and extraction of data from biomedical research and healthcare practice in novel ways.

Full-text (2 Sources)

Available from
Jun 3, 2014